Viewing nowHydron Tablet 150 mg (Sodium Risedronate Monohydrate)
Risedronate Sodium Monohydrate 158.9mg
Tablet · Prescription medication
Huons Co., Ltd.

MFDS item code 201000875 · Approved 2010.01.26 · Insurance code 670605380
Treatment and prevention of osteoporosis in postmenopausal women
This medication is used to prevent and treat osteoporosis commonly occurring in postmenopausal women. The decrease in female hormones due to menopause can weaken bones, and this medicine helps maintain bone health and reduce the risk of fractures. Thus, it effectively improves bone damage due to postmenopausal osteoporosis.
1. Adults : Administer 150 mg of risedronate sodium orally once a month. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), since the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with creatinine clearance of 30 mL/min or higher. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before the first food or beverage other than water of the day. To allow this medicine to reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ∼ 230 mL). Taking this medicine with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take a dose on the scheduled day, follow these instructions. - If the next scheduled dose is 7 days or more away, take 1 tablet the next morning after remembering. Resume the next dose on the originally scheduled day. Do not take more than 1 tablet of this medicine within 7 days. - If the next scheduled dose is within 7 days, wait until the originally scheduled day and then take 1 tablet of this medicine.
3. Children : The safety and efficacy in children under 18 years of age have not been established.
This drug is used as an oral bisphosphonate for the treatment of bone osteoporosis. It may irritate the stomach and esophageal mucosa during use, so caution is required for those with gastritis or esophageal diseases. When taking this drug, it should be taken with sufficient water, and you should remain upright for at least 30 minutes after taking it to reduce esophageal irritation. It should not be used in patients with esophageal stricture, achalasia, hypocalcemia, pregnant or nursing women, and patients with severe renal impairment. Moreover, patients with a history of esophageal disease should use this drug cautiously. Side effects such as esophagitis, esophageal ulcers, abdominal pain, diarrhea, joint pain, muscle pain, headache, dizziness, etc., may occur after taking this medication. In rare cases, serious side effects such as serious esophageal damage or osteonecrosis of the jaw have been reported, so you should consult a physician immediately if symptoms appear. Taking this drug with antacids or supplements containing divalent cations like calcium and magnesium may reduce its absorption, so it is important to space out the dosing times. Additionally, prolonged use of this medication may increase the risk of atypical femoral fractures, so it should be taken according to a doctor's instructions. Avoid using this drug during pregnancy or nursing, and keep it out of reach of children for safety. In case of overdose, symptoms of hypocalcemia may occur, so you should visit a medical institution immediately.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly sealed container to prevent air exposure, and it is best kept at room temperature between 1 degree and 30 degrees. Keeping it this way helps maintain the drug's effectiveness for a longer period.
Bright blue, oblong film-coated tablet
1 tablet (1 tablet/PPT x 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium Monohydrate 158.9mg
Tablet · Prescription medication
Huons Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Guju Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
HK inno.N Co., Ltd.

Risedronate Sodium Monohydrate 37.07mg
Tablet · Prescription medication
Yuhan Corporation

Risedronate Sodium 35mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.

Risedronate Sodium 35mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Risedronate Sodium Monohydrate 37.07mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.